VIR 424B5: Secondary offering

Vir Biotechnology, Inc.

Filed with the SEC on · accession 0001193125-26-458462

VIR filed a 424B5 (prospectus (offering)) with the SEC on Nov 12, 2026. Vir Biotechnology, Inc. filed a preliminary prospectus supplement for a public offering of common stock, with the number of shares and offering price left blank. The stock moved -7.7% by the first close after the filing.

Summary of the filing

Vir Biotechnology, Inc. filed a preliminary prospectus supplement for a public offering of common stock, with the number of shares and offering price left blank. The offering is being underwritten by Leerink Partners, Morgan Stanley, Evercore ISI, and Raymond James.

Key details

IssuerVir Biotechnology, Inc.
UnderwriterLeerink Partners
UnderwriterMorgan Stanley
UnderwriterEvercore ISI
UnderwriterRaymond James

How VIR stock reacted

Close before

$13.13

Nov 11, 2026

First close after

-7.69%

$12.12

5 trading days

—

Since filing

-27.04%

$9.58

✦ Ask GOAX AI about this filing — what it means for VIR, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VIR?

Click here

Frequently asked questions

What did VIR file with the SEC on Nov 12, 2026?

VIR filed a 424B5 (Secondary offering). Vir Biotechnology, Inc. filed a preliminary prospectus supplement for a public offering of common stock, with the number of shares and offering price left blank. The offering is being underwritten by Leerink Partners, Morgan Stanley, Evercore ISI, and Raymond James.

What does a secondary offering mean for VIR stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B5?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did VIR stock react to this filing?

VIR closed at $13.13 before the filing and $12.12 on Nov 12, 2026 (-7.69%).

Other VIR SEC filings

Get alerts when VIR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days